Transcranial direct current stimulation is safe and feasible in hyperacute ischemic stroke (DICAST-SF trial).
Saved in:
| Title: | Transcranial direct current stimulation is safe and feasible in hyperacute ischemic stroke (DICAST-SF trial). |
|---|---|
| Authors: | Slovak M; Department of Neurology and Center for Clinical Neuroscience, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic. Electronic address: matej.slovak@vfn.cz., Kemlink D; Department of Neurology and Center for Clinical Neuroscience, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic., Dusek P; Department of Neurology and Center for Clinical Neuroscience, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic., Rekova P; Department of Neurology and Center for Clinical Neuroscience, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic., Fabian V; Department of Physics, Czech Technical University in Prague, Faculty of Electrical Engineering, Prague, Czech Republic., Jurka M; Department of Radiology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic., Carone D; Brainomix Limited, Oxford, United Kingdom., Perry A; Brainomix Limited, Oxford, United Kingdom., Harston GWJ; Oxford University Hospitals NHSFT, Oxford, United Kingdom., Ruzicka E; Department of Neurology and Center for Clinical Neuroscience, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic., Altmanova D; Department of Radiology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic., Lambert L; Department of Radiology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic; Department of Imaging Methods, Charles University, Second Faculty of Medicine and Motol University Hospital, Prague, Czech Republic., Burgetova A; Department of Radiology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic., Knotkova H; MJHS Institute for Innovation in Palliative Care, New York, NY, United States., Datta A; Soterix Medical Inc., New York, NY, United States., Bikson M; Department of Biomedical Engineering, The City College of New York, New York, NY, United States., Nitsche MA; Leibniz Research Centre for Working Environment and Human Factors, Dortmund, Germany; Bielefeld University, University Hospital OWL, Protestant Hospital of Bethel Foundation, University Clinic of Psychiatry and Psychotherapy, Bielefeld, Germany., Bahr-Hosseini M; Department of Neurology and Comprehensive Stroke Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States., Saver JL; Department of Neurology and Comprehensive Stroke Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States. |
| Source: | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2026 Jan; Vol. 23 (1), pp. e00844. Date of Electronic Publication: 2026 Feb 01. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics Country of Publication: United States NLM ID: 101290381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7479 (Electronic) Linking ISSN: 18787479 NLM ISO Abbreviation: Neurotherapeutics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
